PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
01-May-2024 Significant POLB 001 Patent Granted in United States Poolbeg Pharma plc
01-May-2024 Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer Barinthus Biotherapeutics
01-May-2024 Cytomos offers sneak preview of flagship technology at the London Biotechnology Show 2024 Cytomos
30-Apr-2024 Bioscript Group acquires Enzyme Communications to bolster its medical writing, scientific content creation and storytelling capabilities Bioscript Group
30-Apr-2024 Transformative partnership between the Medicines Patent Pool and ViiV Healthcare enables 24 million people in low- and middle-income countries to access innovative HIV treatment ViiV Healthcare
30-Apr-2024 Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision ImmunomicsTM antigen discovery technologies to target five more cancers Infinitopes Precision Immunomics
30-Apr-2024 Locate Bio Raises £9.2 Million to Progress LDGraft Clinical Study for Anterior Lumbar Interbody Fusion Locate Bio
30-Apr-2024 Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines Benchling
29-Apr-2024 selectION Announces Positive Results from Phase 1b Clinical Trial Evaluating si-544 in Patients with Atopic Dermatitis selectION, Inc.
29-Apr-2024 Monosubstituted Imidazolium-Based Ionic Liquids Newly Released at Alfa Chemistry Alfa Chemistry
26-Apr-2024 Swedencare launches NaturVet by Swedencare: Bringing America’s leading pet brand to Europe Swedencare
26-Apr-2024 OncoZenge Releases Paper on BupiZenge™ Addressing Unmet Medical Needs OncoZenge
26-Apr-2024 Liebherr presents its innovative cooling solutions at Clinical Pharmacy Congress 2024 Liebherr
26-Apr-2024 Creative Enzymes Sets a New Standard with Recombinant Chlorophyllase Creative Enzymes
26-Apr-2024 Creative Enzymes Introduces Highly Efficient Recombinant Pseudomonas sp. Formaldehyde Dehydrogenase, C-His Tag for Enhanced Biocatalysis Creative Enzymes
25-Apr-2024 Lindus Health Debuts "All-in-One Diagnostics CRO" Solution for Diagnostic Clinical Trials Lindus Health
25-Apr-2024 BIAL appoints Pierluigi Antonelli as Non-Executive Board Member BIAL
25-Apr-2024 AAVantgarde announces updated NHP data from its Stargardt disease program in a poster presentation at the ARVO 2024 annual meeting AAVantgarde Bio
25-Apr-2024 V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors V-Bio Ventures
25-Apr-2024 Alfa Chemistry Intensifies Efforts on Transfer, Manufacturing and Modification of Graphene-Based Silicon-Carbon Composites Alfa Chemistry